T lymphocyte homeostatic proliferation, driven by the engagement of T cell antigen receptor with self-peptide/major histocompatibility complexes, and signaling through the common γ-chaincontaining cytokine receptors, is critical for the maintenance of the T cell compartment and is regulated by the Fas death receptor (Fas, CD95). In the absence of Fas, Fas-deficient lymphoproliferation spontaneous mutation (Ipr) mice accumulate homeostatically expanded T cells. The functional consequences of sequential rounds of homeostatic expansion are not well defined. We thus examined the gene expression profiles of murine wild-type and Fas-deficient Ipr CD8 + T cell subsets that have undergone different amounts of homeostatic proliferation as defined by their level of CD44 expression, and the CD4 − CD8 − TCRαβ + T cell subset that results from extensive homeostatic expansion of CD8 + T cells. Our studies show that recurrent T cell homeostatic proliferation results in global gene expression changes, including the progressive upregulation of both cytolytic proteins such as Fas-Ligand and granzyme B as well as inhibitory proteins such as programmed cell death protein 1 (PD-1) and lymphocyte activating 3 (Lag3).
a prominent role in the regulation of T cell homeostatic expansion [26] . T cells from Fasdeficient lymphoproliferation spontaneous mutation (Ipr) (Fas lpr/lpr ) mice accumulated to much greater levels than wild-type T cells during lymphopenia-induced proliferation in Rag1-deficient mice, despite equivalent rates of proliferation [26] . Fas lpr/lpr mice thus manifest an age-dependent lymphadenopathy, even under germ-free conditions, which includes CD44 high CD4 + and CD44 high CD8 + T cells as well as polyclonal CD4 − CD8 − TCRαβ + T cells that derive from CD8 + T cell precursors based on genetic studies [33] [34] [35] [36] [37] [38] . On a genetically susceptible background, Fas lpr/lpr mice also develop an autoimmune syndrome resembling human systemic lupus erythematosus. The same subsets of homeostatically expanding T cells, including CD4 − CD8 − TCRαβ + T cells, also exist in wild-type mice, albeit at substantially lower numbers. Hence, Fas-deficiency does not give rise to a separate lineage of T cells that are unique to Fas lpr/lpr mice, but rather, allows the extended survival of T cells undergoing homeostatic proliferation. As such, the T cells that accumulate in Fas lpr/lpr mice may provide valuable insight into the gene expression profiles of homeostatically expanding CD8 + T cells and why it is important for Fas to limit their survival.
Here, we examined the gene expression profiles of both C57BL/6 wild-type and Fas lpr/lpr CD8 + T cell subsets based on their progressive upregulation of CD44 expression during homeostatic proliferation. These T cell subpopulations represent a continuum in which CD8 + T cells progressively upregulate CD44 expression from low to intermediate to high with repeated cycles of homeostatic proliferation and then finally become CD4 − CD8 − .
Methods

Mice
Mice were bred and housed in the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC)-approved animal facilities of The University of Vermont. All mice in these studies were on a C57BL/6 background and were used between 10 and 13 weeks of age. Original breeding pairs of B6.PL-Thy1 a /Cy (B6.CD90.1, wild-type), B6.MRL-Fas lpr /J (Fas lpr/lpr ), and B6.129S7-Rag1 tm1Mom /J (recombination-activating gene, RAG1-deficient) mice were obtained from Jackson Laboratory (Bar Harbor, ME). Breeding of B6.CD90.1 mice with Fas lpr/lpr mice generated mice homozygous for CD90.1. All animal studies were conducted in accordance with the policies of The University of Vermont's Animal Care and Use Committee.
For the in vivo proliferation studies, mice received four intraperitoneal injections of 1 mg 5bromo-2′-deoxyurindine (BrdU) in sterile phosphate buffered saline (PBS) (Sigma) during the 24 h period prior to tissue harvest. Three injections were given on the day prior to tissue harvest and one injection on the day of sacrifice 1 h prior to tissue harvest.
Lymphocyte preparation
Single cell suspensions of pooled inguinal, brachial, axillary, cervical, and popliteal lymph nodes were prepared in RPMI 1640 (CellGro, Corning, Manassas, VA) containing 25 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (Hepes), 5% v/v bovine calf serum (BCS)(HyClone, Logan, UT), 5 × 10 −5 M β-mercaptoethanol (Sigma, St. Louis, MO), 100 U/ml penicillin, and 100 U/ml streptomycin (Life Technologies-Invitrogen)(RPMI/5% BCS).
To isolate T cell subsets by negative selection, lymph node cells were incubated with the appropriate antibodies (see below), washed, and then incubated by rocking with goat anti-rat and goat anti-mouse IgG-coated beads (Qiagen, Valencia, CA). Antibody-coated cells were removed by magnetic depletion. Cell suspensions were incubated with anti-MHC class II (3F12), anti-CD11b (M1/70), anti-NK1.1 (PK136), anti-kappa (187.1), and anti-CD4 (GK1.5). To obtain CD8 + T cells, anti-CD45R (B220, RA3GB2) was also added. To isolate CD4 − CD8 − TCRαβ + T cells, anti-CD8 (Tib105) was also included.
Naïve CD8 + T cells were isolated using Miltenyi Biotec's naïve CD8α + T cell isolation kit according to the manufacturer's instructions. Naïve CD8 + T cells were then labeled with 4 μM 5-(and 6-)-carboxyfluorescein diacetate succinimidyl ester (CFSE) (Invitrogen) in PBS containing 0.1% w/v bovine serum albumin (BSA)(Sigma) for 10 min at 37°C, washed three times with cold PBS/0.1 % BSA, and resuspended in PBS for adoptive transfer.
Flow cytometry
Single cell suspensions were incubated with Live/Dead Fixable Blue Stain, washed with cold PBS containing 1% w/v BSA (PBS/1%BSA), and then incubated with unconjugated rat IgG and hamster IgG (50 μg/ml each) (MP Biochemicals). After washing, the cells were incubated with the appropriate antibodies in PBS/1% BSA, washed, and fixed with freshly made 1% v/v methanol-free formaldehyde (Ted Pella, Redding CA) in PBS/1%BSA. Flow cytometry was performed on an LSRII (BD Bioscience) and the data were analyzed using FloJo software (TreeStar, Ashland OR).
The following antibodies to murine cell surface proteins were purchased from BD Biosciences (San Jose, CA): Fluorescein isothiocyanate (FITC)-conjugated anti-TCRγδ (GL3), FITC-conjugated anti-BrdU, FITC-conjugated anti-NK1.1 (PK136), allophycocyanin (APC)-conjugated anti-TCRβ (H57-597), Pacific Blue-conjugated anti-CD45R (B220, RA3-6B2). The following antibodies were purchased from Life Technologies-Invitrogen (Grand Island, NY): phycoerythrin (PE)-conjugated anti-CD44 (IM7), PE-Texas Redconjugated anti-CD4 (RM4-5), PE-Texas Red-conjugated anti-CD8 (5H10), PE Cyanine (Cy)5.5-conjugated anti-CD8 (5H10), PE Cy5.5-conjugated anti-CD4 (RM4-5), Pacific Orange-conjugated anti-CD45 (30-F11). The following antibodies were purchased from Biolegend (San Diego, CA): PE-conjugated anti-PD-1 (29F.1.A12), PE-conjugated anti-Lag3 (C9B7W), peridinin chlorophyll protein (PerCP) Cy5.5-conjugated anti-CD4 (RM4-5), PE-Cy7-conjugated anti-TCRβ (H597-597), Alexa Fluor 647-conjugated anti-TCRγδ (UC7-13D5), Alexa Fluor 647-conjugated anti-TCRβ (H597-597), Alexa Fluor 700conjugated anti-CD19 (6D5), APC-Cy7-conjugated anti-CD45R (B220, RA3-6B2), Pacific Blue-conjugated anti-CD19 (6D5), Pacific Blue-conjugated anti-CD44 (IM7). Live/Dead Fixable Blue and Near-IR Dead Cell Stains were purchased from Invitrogen. CD1d-αgalactosyl ceramide tetramer (PBS-57) was obtained from the NIH Tetramer Core Facility.
Staining for DNA-incorporated BrdU was performed as described previously [26] . In brief, cells from BrdU-pulsed mice were incubated with Live/Dead stain followed by rat and hamster IgG as described above. The cells were stained for expression of cell surface proteins, and then fixed with 70% ethanol (−20°C) followed by 1% v/v methanolfree formaldehyde in PBS. The cells were permeablized in PBS containing 1% v/v methanol-free formaldehyde and 0.01% v/v Tween-20 overnight at 4°C. The cells were incubated with 50 Kunitz units of DNase I (Sigma) in 150 mM NaCl (pH=5) containing 4.2 mM MgCl 2 for 15 min at 37°C, incubated with anti-BrdU FITC (BD Biosciences), and fixed in 1% v/v formaldehyde in PBS/1% BSA.
Immunoblot analysis
Cells were lysed in buffer containing 0.5% Nonidet P-40, 20 mM Tris-HCl (pH=7.4), 150 mM NaCl, 2 mM sodium orthovanadate, 10% glycerol, and complete protease inhibitor (Roche Diagnostics, Indianapolis, IN). Protein concentration was determined by Bradford assay (Bio-rad, Hercules, CA). Protein lysates were separated by SDS-PAGE using 12.5% acrylamide gels and transferred to Immobilon-FL (Millipore, Billerica, MA) membranes. Membranes were blocked with 4% w/v milk in PBS and then incubated with primary antibody in PBS containing 4% milk and 0.1% v/v Tween-20 overnight at 4°C. After washing with PBS containing 0.1% Tween-20, membranes were incubated with fluorescentconjugated species-specific secondary antibodies in PBS containing 4% milk, 0.1% Tween-20, and 0.01% SDS. Images were acquired with an Odyssey CLx using Image Studio software (LI-COR, Lincoln, NE). The fluorescence signals for each sample were background subtracted and normalized to α-tubulin using Image Studio software. The following antibodies were used for immunoblot analysis: anti-Fasligand (FasL) (R&D Systems, MAB5262), anti-α-tubulin (Cell Signaling Technology), anti-granzyme B (Cell Signaling Technology), IRDye 800CW goat anti-rat (LI-COR), IRDye 680RD goat antimouse IgG1 (LI-COR), IRDye 800CW goat anti-rabbit (LI-COR).
Assay of cytolytic activity
T cell suspensions were resuspended in RPMI 1640 supplemented with 25 mM Hepes, 2500 μg/ml glucose, 10 μg/ml folate, 110.04 μg/ml pyruvate (Life Technologies-Gibco), 5 × 10 −5 M β-mercaptoethanol, 292.3 μg/ml glutamine, 100U/ml penicillin, 100U/ml streptomycin, and 5% v/v bovine calf serum, and plated at 37°C for 2 h. Jurkat T cell targets were incubated with 51 Cr for 1 h at 37°C, washed three times, and then mixed with the freshly isolated T cell effectors at an effector:target ratio of 10:1. After incubating at 37°C for 4 h, co-culture supernatants were removed and counted for gamma emission. Spontaneous release was determined from labeled targets in the absence of effector cells. Maximal Fasmediated 51 Cr release was measured by culturing Jurkat T cells with 250 ng/ml FLAG™tagged recombinant FasL (Alexis Biochemicals) plus anti-FLAG™ antibody (Sigma) for 4 h. The percentage of 51 Cr release was calculated as: % cytolysis=[(experimental cpmspontaneous cpm)/FasL cpm-spontaneous cpm)].
Bisulfite Sequencing
Genomic DNA was prepared using the Quick gDNA Micro Prep Kit (Zymo Research) according to the manufacturer's instructions. Bisulfite sequencing was adapted from Youngblood et al [39] . Briefly, genomic DNA was bisulfite treated using the EZ DNA Methylation Gold Kit (Zymo Research). Bisulfite-converted DNA was amplified via region specific primers and cloned using the TOPO TA cloning kit (Life Technologies). Individual colonies were selected from three biological replicates, sequenced, and significance determined by a Fischer's Exact Test.
Microarray sample preparation
Single cell suspensions were prepared from inguinal, brachial, axillary, cervical, and popliteal lymph nodes. Lymph node cells from five 10-week old female wild-type mice were pooled and stained with live/dead stain followed by antibodies for CD4, CD8, TCRβ, CD44, CD19, TCRγδ, and CD1d tetramer (Natural Killer T (NKT) cells). The CD8 + TCRαβ + subset was sorted into CD44 low , CD44 intermediate , and CD44 high populations. CD4 − CD8 − TCRαβ + T cells were identified as TCRβ + CD19 − TCRγδ − CD1d tetramer − . For Fas lpr/lpr samples, lymph node cells from three 10-week old female Fas lpr/lpr mice were pooled and stained with live/dead stain followed by antibodies for CD4, CD8, TCRβ, CD44, CD45R, and NK1.1. CD4 − CD8 − TCRαβ + T cells were identified as TCRβ + CD44 + CD45R + NK1.1 − . All sorts were performed on a FACSAria (BD Bioscience). Sort purity was >97% for all populations. Total RNA was prepared from sorted T cell subsets using RNeasy Micro Kit (Qiagen) according to manufacturer's instructions.
Microarray and data processing
RNA was processed, amplified, labeled, and hybridized to Affymetrix GeneChip Mouse 430 2.0 in the Vermont Genetics Network Microarray Facility. The signal intensity for each probe on each chip was calculated from scanned images using GeneChip Operating Software (Affymetrix). Calculations were performed using the R language and environment for statistical computing and graphics [40] with Bioconductor packages [41] . Probe intensities were background corrected, normalized, and summarized using the Robust Multiarray Analysis (RMA) method as implemented in the affy package using the default settings.
A probe set was retained if it was called "present" in at least three samples based on the mas5 procedure in the affy package [42] .
Heat map construction
The wild-type and Fas lpr/lpr expression matrices were joined using the 26,738 probe sets detected in both data sets and the top 2 −8 (105) probe sets with respect to variance were selected without regard for the fit to any statistical model. The heat map was constructed using the heatmap.2 function in the gplots package. The column dendrogram was constructed using the complete linkage option and the Euclidean distance between profiles.
Principal component analysis
Wild-type and Fas lpr/lpr expression statistics were expressed relative to the CD8 + CD44 low profiles from the same experimental batch and the CD8 + CD44 low samples were set to the origin. The wild-type and Fas lpr/lpr expression matrices were then joined based on probe sets called present in both sets. Principal component scores and loadings were obtained using the prcomp procedure from the R stats package (uncentered, unscaled) . To obtain a real-valued measure of the contribution of each gene to the departure of the CD4 − CD8 − TCRαβ + T cells with respect to the path from CD8 + CD44 low to CD44 intermediate to CD44 high , we used the displacement of the sample scores for the CD4 − CD8 − TCRαβ + T cells along a line perpendicular to a line fit to our CD8 + T cell subsets.
Identification of patterns of gene expression across samples
To identify patterns of probe set expression across samples, the top 2 −3 probe sets (3, 343) with respect to overall variation, from the combined wild-type and Fas lpr/lpr expression matrices (26,738 probe sets), were selected and each assigned to one of eight classes using the k-means algorithm. Each sample was expressed relative to the CD8 + CD44 low (L) sample of the same batch and the profiles of genes were scaled across samples to have the same variance. We then used the k-means procedure in the R stats package with default options, specifying eight clusters.
Results
Surface levels of CD44 expression reflect progressive rounds of homeostatic proliferation
Surface levels of CD44 expression are upregulated following T cell receptor for antigen (TCR) activation and cell proliferation [43] . We considered that CD44 might be progressively upregulated in vivo during T cell homeostatic proliferation. Following adoptive transfer of CD44 low T cells into Rag1-deficient recipients, T cell homeostatic expansion was induced and CD44 expression was progressively upregulated with each cell cycle ( Fig. 1A, B ). Furthermore, spontaneous cell cycling of T cells from C57BL/6 wildtype and Fas lpr/lpr mice in vivo, as measured by BrdU incorporation, showed that the fraction of CD8 + T cells that incorporated BrdU progressively increased with increasing levels of CD44 expression ( Fig. 1C, D) . These data are consistent with the view that CD44 is upregulated during homeostatic proliferation and serves as a biomarker of this process. Of interest, CD4 − CD8 − TCRαβ + CD44 high T cells manifested a substantial rate of BrdU incorporation (18%) in a 24 h period (Fig. 1C, D ), yet they exhibited a reduced cell size as measured by forward scatter compared with CD8 + CD44 high T cells, their likely precursor ( Fig. 1E ). Since pre-existing Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells do not proliferate either in vivo or in vitro (K. A. F. unpublished data) [33] , these data suggested that cell cycling occurred in the precursor CD8 + T cells just prior to the transition to the CD4 − CD8 − phenotype and that once converted, cell cycling was rapidly arrested.
Continued T cell homeostatic proliferation results in changes in gene expression
To determine the functional consequences of recurrent T cell homeostatic proliferation, we analyzed the gene expression profiles of CD8 + T cell subsets from both C57BL/6 wild-type and Fas lpr/lpr mice based on their levels of CD44 expression (low, intermediate, and high) and CD4 − CD8 − TCRαβ + T cells which express high levels of CD44 ( Fig. 2A, B ). We chose to perform our studies using C57BL/6 Fas lpr/lpr mice, which manifest lymphadenopathy but limited renal pathology and autoantibody production, in order to analyze changes in T cell gene expression due to homeostatic proliferation in the absence of the autoinflammation and autoimmune disease that develops in MRL-Fas lpr mice. A small subpopulation of CD4 − CD8 − TCRαβ + T cells that lacked staining for TCRγδ, CD19, and CD1d-α-galactosyl ceramide tetramer (which identifies NKT cells) was present in wild-type mice, although there were relatively few of these cells (~0.6% of TCRαβ + non-NKT cells) presumably due to Fas-mediated cell death ( Fig. 2A ). By contrast, CD4 − CD8 − TCRαβ + T cells were abundant in Fas lpr/lpr mice (Fig. 2B ). The CD4 − CD8 − TCRαβ + T cells in wild-type mice likely represent recently generated CD4 − CD8 − TCRαβ + T cells since they are rapidly eliminated in a Fas-dependent manner, whereas Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells persist.
Three independent sorts were performed on the combined lymph node cells from 3-5 mice for each genotype and were highly consistent. The four T cell subsets were readily distinguishable based on their gene expression patterns as shown in the heat map and sample-to-sample distances of the dendrogram (Fig. 2C ). The CD8 + T cell subsets from wild-type and Fas lpr/lpr mice bearing similar CD44 expression manifested very similar gene expression profiles. This is consistent with the view that the increased number of Fas lpr/lpr T cells results merely from the accumulation of T cells that would normally be eliminated by Fas-mediated cell death and are not an aberrant linage.
Principal component analysis revealed that 87% of the variation among the samples was captured by the first three principal components (PC) ( Fig. 2D ). PC1 and PC2 defined a line from CD8 + CD44 low to CD8 + CD44 intermediate to CD8 + CD44 high to wild-type CD4 − CD8 − TCRαβ + T cells and also defined the gene expression that distinguished Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells from the other subsets ( Fig. 2E ). PC1 and PC3 identified the shared gene expression between wild-type and Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells and distinguished them from the CD8 + T cell subsets ( Fig 2F) . PC2 and PC3 revealed the differences between wild-type and Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells ( Fig 2G) . This principal component analysis is consistent with a model in which gene expression changed progressively with continued homeostatic proliferation of CD8 + T cells along a path from CD44 low to CD44 intermediate to CD44 high and finally to CD4 − CD8 − TCRαβ + T cells. CD4 − CD8 − TCRαβ + T cells from wild-type mice shared features most closely with CD8 + CD44 high T cells, consistent with being recently-derived from CD8 + T cell precursors ( Fig. 2E ). Wild-type and Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells had substantially similar gene expression ( Fig. 2F ), which likely reflects their common lineage, despite some differences ( Fig. 2E , G).
Mathematical modeling of the changes in the gene expression profiles of wild-type and Fas lpr/lpr T cells using differential geometry further demonstrated the similarities between equivalent subsets in wild-type and Fas lpr/lpr mice, including the CD4 − CD8 − TCRαβ + T cells (Supplemental Fig. 1A) . Evaluation of the genes that differ specifically between CD4 − CD8 − TCRαβ + T cells and their respective CD8 + T cell subsets using Fisher's exact test showed there was a very strong association (p<10 −15 ) between wild-type and Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells (Supplemental Fig. 1B ). Collectively, these analyses underscore the fact that although wild-type CD4 − CD8 − TCRαβ + T cells are present in only small numbers, they likely have a similar lineage derivation as Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells. 
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Gene expression patterns reveal substantial increases and decreases with recurrent homeostatic proliferation
To identify patterns of gene expression during progressive rounds of homeostatic proliferation, the most differentially expressed probe sets were assigned to one of eight clusters based on their gene expression pattern, and the consensus expression profile determined for each cluster (Fig. 3) . A subset of genes either progressively increased or decreased expression in a step-wise manner (Fig. 3A , E) as CD8 + T cells progressed from CD44 low to CD44 intermediate to CD44 high to CD4 − CD8 − TCRαβ + T cells. This likely reflects the continuous changes in expression as T cells progress through multiple cycles of homeostatic proliferation and supports the view that CD4 − CD8 − TCRαβ + T cells are an extension of the CD8 + T cell subsets. In two patterns ( Fig. 3B , F), gene expression was strongly upregulated only as the CD8 + T cells became CD44 high and continued in wild-type CD4 − CD8 − TCRαβ + T cells, undergoing a further change in Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells. This suggested that a subset of CD8 + CD44 high T cells shares a phenotype with CD4 − CD8 − TCRαβ + T cells. Four additional patterns ( Fig. 3C , D, F, G) revealed that gene expression differed between wild-type and Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells, indicating that gene expression is further altered with the extended survival of CD4 − CD8 − TCRαβ + T cells in Fas lpr/lpr mice. The final pattern ( Fig. 3H ) showed that a small subset of genes was upregulated selectively in wild-type CD4 − CD8 − TCRαβ + T cells. The genes associated with these expression patterns are summarized in Supplemental Table 1 and a subset of genes is highlighted in Table 1 .
Genes in each pattern were analyzed for highly represented biological processes using Gene Ontology enrichment analysis (Supplementary Table 2 ). Genes progressively increasing in expression ( 
Recurrent T cell homeostatic proliferation results in changes in expression of genes that regulate cytolytic activity, proliferation, and survival
A number of genes whose expression changes during homeostatic proliferation have important implications for immune function. Expression of a large number of genes involved in transcription were progressively increased or decreased with recurrent homeostatic proliferation ( Fig. 4 , Table 1 ). Of particular interest, Eomes and Tbx21, that coordinately upregulated as CD8 + T cells increased CD44 expression ( Fig. 4A, B , Table 1 ). Genes regulating cell cycling, including E2f2, the cyclins Ccnb2 and Ccna2, and the cell cycle inhibitors Wee1 and Jdp2, were progressively upregulated as CD8 + T cells transitioned from CD44 low to CD44 high and finally to CD4 − CD8 − (Fig. 4C , D, Table 1 ). Expression of Wee1 and Jpd2 were particularly increased in Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells, suggesting that further cell cycling is blocked in these T cells. Expression of the effector caspase, Casp3, was also progressively upregulated, potentially priming the cells for death ( Fig. 4E ). Furthermore, Il7rα expression was profoundly downmodulated in Fas lpr/lpr CD4 − CD8 − TCRαβ + cells (Fig. 4F ), which may further limit their expansion.
Changes in expression of genes involved in the effector function of CD8 + T cells gave insight into the consequences of continued homeostatic expansion. Strikingly, the effector molecules FasL, Gzmb, and Ifng were upregulated during homeostatic proliferation ( Fig.  4G -I, Table 1 ). The activating receptor Klrk1 (NKG2D) which enhances CD8 + T cell cytotoxicity was also increased in both wild-type and Fas lpr/lpr CD8 + CD44 high and wild-type CD4 − CD8 − TCRαβ + T cells, but downregulated in Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells (Fig. 4J ). The costimulatory receptor Cd160 was expressed in all T cell subsets except Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells (Fig. 4K ). The inhibitory molecules Lag3 (lymphocyte activating 3, CD223), Pdcd1 (programmed cell death protein 1, PD-1, CD279), Pdcd1lg2 (PD-1-ligand 2), and Il10 were progressively upregulated as CD8 + T cells transitioned from CD44 low to CD44 high and finally to CD4 − CD8 − in both wild-type and Fas lpr/lpr mice ( Fig.   4L -O, Table 1 ). The upregulation of this suite of genes suggested that CD8 + T cells undergoing chronic homeostatic proliferation acquire both cytolytic function and potential immune inhibitory function. Furthermore, wild-type CD4 − CD8 − TCRαβ + T cells manifest elevated levels of the chemokine receptors Ccr2 and Ccr5 and the integrins Itga1, Itga4, and Itgav which function in recruitment and migration into non-lymphoid tissues ( Table 1 ).
The profound upregulation of Fasl and Gzmb gene expression in both Fas lpr/lpr and wildtype CD4 − CD8 − TCRαβ + T cells suggested that these T cells might be capable of antigenindependent cytolytic activity. Elevated expression of FasL and Granzyme B protein by Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells was confirmed by western analysis (Fig. 5A, B ). In addition, freshly isolated Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells induced cytolysis of Jurkat T cell targets at a level five times that of wild-type CD8 + T cells (Fig. 5C ). Thus, Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells are functionally capable of killing Fas-susceptible target cells without additional activation.
PD-1 is upregulated on both wild-type and Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells and regulated by gene methylation
Consistent with the upregulation of Pdcd1 and Lag3 gene expression ( Fig. 4L, M) , cell surface protein expression of PD-1 and Lag3 increased progressively from CD8 + CD44 low to CD44 high (Fig. 6A-C) . PD-1 expression was moderately increased on wild-type CD4 − CD8 − TCRαβ + T cells and was strongly upregulated on Fas lpr/lpr CD4 − CD8 − TCRαβ + a phenotype similar to Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells, manifested increased PD-1 expression compared with the subset bearing less CD44, suggesting that the T cells that had undergone the most extensive homeostatic proliferation upregulated PD-1. Of note, a small subset of CD8 + CD44 high T cells had also upregulated PD-1 in both wild-type and Fas lpr/lpr mice, consistent with the model that a subset of CD8 + CD44 high T cells shares a phenotype with CD4 − CD8 − TCRαβ + T cells, and thus may be the most immediate precursor.
Expression of PD-1 by T cells is known to be epigenetically regulated [39] . We therefore examined the extent of DNA methylation in the Pdcd1 transcriptional regulatory conserved region B (CR-B) and CR-C by bisulfite sequencing of genomic DNA from CD8 + and CD4 − CD8 − TCRαβ + T cells from Fas lpr/lpr mice. Fas lpr/lpr CD8 + T cells manifested a highly methylated CR-B region and partially demethylated CR-C region, similar to that reported for naïve T cells (Fig. 6D ) [39] . In contrast, Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells had a partially demethylated CR-B region and an almost completely demethylated CR-C region, consistent with their elevated expression of Pdcd1. While the methylation state of CR-B bears similarities to that reported for virus-specific memory CD8 + T cells, CR-C more closely resembles that of CD8 + T cells continually exposed to antigen during chronic infections [39] .
Discussion
The current findings reveal that among the global changes in gene expression as CD8 + T cells undergo sequential rounds of homeostatic proliferation are molecules that could provoke either an autoinflammatory process (Fasl and Gzmb) or immune inhibition (Pdcd1, Lag3, Il10 and Pdcd1l2). These findings underscore the importance of regulating homeostatically expanding T cells. Our studies examined the gene expression profiles of CD8 + T cell subpopulations representing a continuum of homeostatic proliferation, following which a portion of the CD8 + T cells become CD4 − CD8 − [26] . The small number of CD4 − CD8 − TCRαβ + T cells in wild-type mice are probably recently derived from their CD8 + precursors since they are promptly eliminated by Fas [26] . In Fas lpr/lpr mice, CD8 + CD44 high and CD4 − CD8 − TCRαβ + T cells accumulate and represent subpopulations that have likely undergone more extensive homeostatic proliferation. Thus, the absence of Fas does not give rise to T cell subsets that are unique to Fas lpr/lpr mice, but rather allows the accumulation of T cells that normally arise in wild-type mice but are quickly eliminated by Fas. As such, gene expression analysis of these T cell subsets provides insight into the regulation and function of T cells undergoing chronic TCR stimulation.
Our findings provide insight into why it is critical to limit the accumulation of homeostatically expanding T cells. CD8 + CD44 high and CD4 − CD8 − TCRαβ + T cells from both wild-type and Fas lpr/lpr mice manifest increased levels of Ifng, Fasl, Gzmb, and Gzmk gene expression. CD8 + CD44 high and wild-type CD4 − CD8 − TCRαβ + T cells also express the costimulatory receptors Klrk1 (NKG2D) and Cd160 that have been shown to enhance cytolytic responses [48, 49] , and yet have only a modest increase in the inhibitory receptors Pdcd1 and Lag3. Thus, CD8 + CD44 high and recently derived CD4 − CD8 − TCRαβ + T cells may be particularly potent mediators of inflammatory damage, without yet manifesting inhibition by PD-1 and Lag3. In the absence of Fas-mediated cell death, further gene expression changes occur in Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells, including strongly increased expression of Pdcd1 and Lag3 as well as Il10 and Pdcd1l2. This suggests upregulation of a further regulatory program in Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells to control their function, since they continue to express high levels of mRNA for Ifng, Fasl, Gzmb, and Gzmk. As wild-type mice express Fas on most tissues, the progressive upregulation of FasL could be particularly deleterious in wild-type mice. Consistent with this view are earlier findings that deletion of Fas selectively in T cells resulted in their increased FasL expression and an inflammatory fibrotic lung condition that was prevented with anti-FasL blocking antibody [50] . Moreover, Autoimmune Lymphoproliferation Syndrome (ALPS) patients [51, 52] , who have inherited genetic defects in proteins that mediate lymphocyte apoptosis including Fas, manifest elevated levels of plasma FasL and IL-10 [53, 54] .
Our studies also offer an explanation for the activated phenotype and distinctive cell cycle status of Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells. Previous genetic and functional studies have shown that Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells arise from CD8 + T cell precursors as a consequence of persistent homeostatic proliferation in conjunction with reduced cell death [35] [36] [37] [38] 55] and not as a consequence of a defect in thymic negative selection nor the contraction of T cell expansion following acute infection [56] [57] [58] [59] [60] . Consistent with their origin from CD8 + T cells receiving chronic TCR stimulation, Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells have an activated phenotype that is characterized by high levels of active Fyn as well as the constitutive phosphorylation of a number of TCR signaling proteins including CD3ζ [61] [62] [63] . Yet, when examined ex vivo, Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells are not actively cycling [38, 64] , and they do not proliferate following adoptive transfer into Rag1-deficient mice (K. A. F. unpublished data). This implies that their proliferation likely occurred immediately prior to the transition from CD8 + precursor to CD4 − CD8 − TCRαβ + T cell and that this transition is rapidly followed by cell cycle arrest. A number of proteins could contribute to the cessation of cell cycling including reduced expression of IL-7Rα and increased expression of the cell cycle inhibitors Wee1 and Jdp2 as well as the inhibitory proteins PD-1 and Lag3. Lag3 limits T cell homeostatic proliferation and mice deficient for Lag3 have a two-fold increase in T cells compared with wild-type controls [65, 66] . Other proteins that may impact the proliferation and survival of CD4 − CD8 − TCRαβ + T cells are the signaling lymphocyte activation molecule (SLAM) family members which act as important immunomodulatory receptors [67] , as SLAMF7 expression is increased in this subset (Table I) . Consistent with this, Fas lpr/lpr mice bearing a mutation in the downstream signaling molecule for SLAM proteins, SLAM-associated protein (SAP), do not develop adenopathy or autoimmune disease [68] . The SLAM locus has also been linked with susceptibility to systemic lupus erythematosus [69, 70] .
Progressive homeostatic proliferation may generate a subpopulation of CD8 + T cells, identified by high levels of CD44, PD-1, FasL, and IL-10 that could also function as immunosuppressive CD8 + T regulatory cells. This phenotype also provides an explanation for the previous observations showing that Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells are hyporesponsive to TCR stimulation in vitro and yet can suppress allogeneic skin grafts and are cytolytic in vitro [33, 71] . Thus, despite their hyporesponsiveness, they are not functionally inert. Of note in this regard, CD4 + T regulatory cells, like CD4 − CD8 − TCRαβ + T cells, also manifest a high rate of homeostatic proliferation (K. A. F. unpublished observations) and express many of the same effector and inhibitory proteins as CD4 − CD8 − TCRαβ + T cells [72] . Hence, our observations regarding the gene expression changes in homeostatically expanding CD8 + T cells may also apply to CD4 + T cells and, potentially to B cells, as it was recently observed that immunosuppressive IL-10-producing B cells preferentially repopulate the B cell pool following depletion with anti-CD20 Rituximab [73] .
Our studies reveal that Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells share features with the gene expression profile reported for antigen-specific exhausted T cells in chronic LCMV infection (Supplemental Fig. 2 ) [74, 75] . During chronic infections, persistent antigen stimulation results in global transcriptional changes including the progressive upregulation of a number of inflammatory (FasL, granzyme B) and inhibitory (PD-1, Lag3) proteins and reduced CD122 and CD127, leading to the loss of effector functions [76] . Homeostatic proliferation is similarly driven by chronic TCR stimulation from low affinity interactions with selfpeptide/MHC combined with IL-7 and IL-15 in the absence of inflammation [1] [2] [3] [4] [5] [77] [78] [79] . Thus, Fas lpr/lpr CD4 − CD8 − TCRαβ + T cells may provide insight into a common gene expression profile used to regulate chronically stimulated T cells. In this regard, Fas also contributes to T cell deletion during chronic viral infection [57, 80, 81] . This suggests that chronic TCR stimulation leads to a unique cellular state in which the additional death signal provided by Fas is needed to eliminate unwanted, potentially inflammatory T cells.
Homeostatic proliferation makes a substantial contribution to both the neonatal immune system and maintenance of the T cell compartment with age [30, 82] . The functional changes that can result from persistent homeostatic expansion may provide a partial explanation for the reduced immune response to vaccination and increased susceptibility to infection observed in newborns and the elderly. Consistent with this, T cells in aged individuals have an increased portion of CD44 high T cells and inhibitory protein expression including PD-1 [83] [84] [85] . Augmented homeostatic proliferation may also be an underlying mechanism in the development of certain autoinflammatory syndromes. Autoinflammatory sequelae are associated with treatment-induced lymphopenia following chemotherapy and bone marrow transplants as well as following chronic viral infections [19, 20, 86] . Rapid T cell proliferation has also been observed in HIV-infected individuals, who can manifest a variety of autoinflammatory syndromes, such as psoriasis and psoriatic arthritis [18, 87] . Moreover, elevated rates of homeostatic expansion have been reported with autoimmune disorders including rheumatoid arthritis and systemic lupus erythematosus [8, 9, 88] , and an increase in CD4 − CD8 − TCRαβ + T cells has been observed in patients with systemic lupus erythematosus [9] . Our findings thus provide new insight into the process by which augmented T cell homeostatic expansion could lead to the two paradoxical clinical immunological scenarios of either immune deficiency complicated by autoimmune manifestations or, conversely, autoimmune disease in association with increased susceptibility to infection. 
. Equivalent subsets of wild-type and Fas lpr/lpr T cells manifest very similar gene expression profiles
(A) Freshly isolated lymph node cells from five 10-week old C57BL/6 wild-type mice were pooled and stained for CD4, CD8, TCRβ, CD44, CD19, TCRγδ, and NKT tetramer. 
